MedPath

Desflurane

Generic Name
Desflurane
Brand Names
Suprane
Drug Type
Small Molecule
Chemical Formula
C3H2F6O
CAS Number
57041-67-5
Unique Ingredient Identifier
CRS35BZ94Q

Overview

Desflurane, or I-653, a a volatile anesthetic that is more rapidly cleared and less metabolized than previous inhaled anesthetics such as methoxyflurane, sevoflurane, enflurane, or isoflurane.. It was developed in the late 1980s out of a need for a more rapidly acting and rapidly cleared inhaled anesthetic. Desflurane was granted FDA approval on 18 September 1992.

Background

Desflurane, or I-653, a a volatile anesthetic that is more rapidly cleared and less metabolized than previous inhaled anesthetics such as methoxyflurane, sevoflurane, enflurane, or isoflurane.. It was developed in the late 1980s out of a need for a more rapidly acting and rapidly cleared inhaled anesthetic. Desflurane was granted FDA approval on 18 September 1992.

Indication

Desflurane is indicated for the induction and maintenance of anesthesia in adults, as well as the maintenance of anesthesia in pediatric patients.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/06/11
Not Applicable
Recruiting
2025/01/17
Phase 4
Not yet recruiting
Georgia Tsaousi
2025/01/13
Not Applicable
Not yet recruiting
Xiaguang Duan
2024/06/13
Phase 4
Withdrawn
Kocaeli City Hospital
2024/02/09
Not Applicable
Not yet recruiting
2024/02/05
Early Phase 1
Not yet recruiting
Sichuan Provincial People's Hospital
2023/12/19
Not Applicable
Recruiting
2023/11/09
Not Applicable
Not yet recruiting
Ajou University School of Medicine
2023/09/06
N/A
Completed
Recep Tayyip Erdogan University
2023/08/14
Phase 4
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Henry Schein, Inc.
0404-9961
RESPIRATORY (INHALATION)
240 mL in 240 mL
11/16/2023
General Injectables & Vaccines, Inc
52584-641
RESPIRATORY (INHALATION)
240 mL in 240 mL
12/27/2022
Piramal Critical Care Inc
66794-021
RESPIRATORY (INHALATION)
250 mL in 250 mL
2/28/2023
Baxter Healthcare Corporation
10019-641
RESPIRATORY (INHALATION)
240 mL in 240 mL
2/22/2023
Baxter Healthcare Corporation
10019-644
RESPIRATORY (INHALATION)
240 mL in 240 mL
2/26/2015
Baxter Healthcare Corporation
10019-646
RESPIRATORY (INHALATION)
240 mL in 240 mL
2/26/2015
Sandoz Inc.
0781-6172
RESPIRATORY (INHALATION)
240 mL in 240 mL
11/8/2022

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
SUPRANE INHALATION ANAESTHETIC
SIN08818P
SOLUTION
100%
8/6/1996

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Desflurane
国药准字H20168004
化学药品
原料药
3/26/2021
Desflurane
国药准字HJ20170089
化学药品
溶液剂
3/1/2024
Desflurane
国药准字H20100010
化学药品
原料药
10/23/2019
Desflurane
国药准字H20143157
化学药品
原料药
8/6/2024
Desflurane
国药准字H20130120
化学药品
原料药
10/15/2023
Desflurane
国药准字H20113167
化学药品
N/A
5/10/2021
Desflurane
国药准字H20100054
化学药品
原料药
4/8/2020
Desflurane
国药准字H20100059
化学药品
原料药
9/30/2024
Desflurane, Liquid for Inhalation
国药准字H20183269
化学药品
吸入制剂
4/12/2023

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

© Copyright 2025. All Rights Reserved by MedPath